Aldagen, a biopharmaceutical company, has received orphan drug designation for ALD-101 from the FDA. The designation was granted for the use of ALD-101 to improve patient outcomes by decreasing time to platelet and neutrophil engraftment in patients with inherited metabolic disorders undergoing umbilical cord blood transplantation.
Original post by Yahoo! News Search Results for cord blood

At the local hospital near you, right now, babies are being born with over 200 industrial chemicals in their cord blood.
Original post by Yahoo! News Search Results for cord blood

FDNY Survivor of Bus Accident Returns after 68 blood transfusions, 3-year recovery
Original post by Yahoo! News Search Results for cord blood